Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020

被引：1
|
作者：
Essa, Mohammed [2 ]
Ross, Joseph S. S. [3 ,4 ,5 ]
Dhruva, Sanket S. S. [6 ]
Desai, Nihar R. R. [7 ]
Yeh, Robert W. W. [8 ]
Faridi, Kamil F. F. [1 ,7 ]
机构：
[1] Yale Sch Med, Dept Med, Sect Cardiovasc Med, Courier 333 Cedar St,Off 310 Dana, New Haven, CT 06520 USA
[2] Catholic Med Ctr, New England Heart & Vasc Inst, Manchester, NH USA
[3] Yale New Haven Hlth Syst, Ctr Outcomes Res & Evaluat, New Haven, CT USA
[4] Yale Sch Med, Dept Med, Sect Gen Internal Med, New Haven, CT 06520 USA
[5] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA
[6] Univ Calif San Francisco, Sch Med, Dept Med, Sect Cardiol, San Francisco, CA USA
[7] Yale New Haven Hlth Syst, Ctr Outcomes Res & Evaluat, Yale Sch Med, Sect Cardiovasc Med,Dept Med, New Haven, CT USA
[8] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2023年 / 12卷 / 08期
关键词：
clopidogrel; medication costs; prasugrel; ticagrelor;
D O I：
10.1161/JAHA.122.028869
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Answer Regarding: Potent P2Y12 Inhibitors and Bleeding Complications
    Akinci, Sinan
    Coner, Ali
    Akbay, Ertan
    Adar, Adem
    Muderrisoglu, Haldun
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2022, 50 (07): : 545 - 546
  • [32] P2Y12 inhibitors in neuroendovascular surgery: An opportunity for precision medicine
    Rosengart, Axel
    Collins, Malie K.
    Hendrix, Philipp
    Uber, Ryley
    Sartori, Melissa
    Jain, Abhi
    Mao, Jennifer
    Goren, Oded
    Schirmer, Clemens M.
    Griessenauer, Christoph J.
    INTERVENTIONAL NEURORADIOLOGY, 2021, 27 (05) : 682 - 694
  • [33] Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors
    Winter, Max-Paul
    Grove, Erik L.
    De Caterina, Raffaele
    Gorog, Diana A.
    Ahrens, Ingo
    Geisler, Tobias
    Gurbel, Paul A.
    Tantry, Udaya
    Navarese, Eliano P.
    Siller-Matula, Jolanta M.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2017, 3 (04) : 221 - 234
  • [34] Effect of P2Y12 inhibitors on thrombus stability and endogenous fibrinolysis
    Spinthakis, Nikolaos
    Farag, Mohamed
    Gue, Ying X.
    Srinivasan, Manivannan
    Wellsted, David M.
    Gorog, Diana A.
    THROMBOSIS RESEARCH, 2019, 173 : 102 - 108
  • [35] P2Y12 receptor inhibitors for secondary prevention of ischemic stroke
    Liu, Fang
    Tantry, Udaya S.
    Gurbel, Paul A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (08) : 1149 - 1165
  • [36] Comparison of Oral P2Y12 Inhibitors in Acute Coronary Syndrome
    Ferracane, Elisa
    Bartoli, Laura
    Trippoli, Sabrina
    Messori, Andrea
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 135 : 183 - 184
  • [37] New P2Y12 inhibitors for the treatment of coronary artery disease
    Gurbel, P. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 4 - 5
  • [38] Aspirin and P2Y12 inhibitors in treating COVID-19
    Khalaji, Amirmohammad
    Behnoush, Amir Hossein
    Peiman, Soheil
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 110 : 101 - 103
  • [39] Aspirin vs P2Y12 Inhibitors A Few Questions Unanswered
    Mostafa, Mostafa Reda
    Abdou, Claudine
    Barssoum, Kirolos
    Jneid, Hani
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (01) : e7 - e7
  • [40] Clinical effects and outcomes with new P2Y12 inhibitors in ACS
    Collet, Jean-Philippe
    O'Connor, Stephen
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (01) : 16 - 18
12345